Entrepreneurs from Asian Countries and Regions Compete at AEA2024 Innovation Award held in Kashiwa-no-ha

December 05, 2024 10:00 AM IST | By Businesswire India
 Entrepreneurs from Asian Countries and Regions Compete at AEA2024 Innovation Award held in Kashiwa-no-ha
Image source: Businesswire India
Business Wire India

This year’s winner: Entomal Biotech from Malaysia, offering biotech waste management solution that converts organic waste into insect protein and fertilizer

Kisui TECH from Japan wins Kashiwa-no-ha Award and places third overall with its autonomous AI off-road platform supporting agriculture


The Asian Entrepreneurship Award (AEA) Steering Committee is pleased to announce that AEA2024, the 13th annual innovation award event for fast-growing Asian startups, was held on November 20th and 21st. Taking place in-person for the first time in five years, the event was held at Kashiwa-no-ha Smart City in Chiba prefecture.  

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241201757611/en/  

Entrepreneurs from Asian Countries and Regions Compete at AEA2024 Innovation Award held in Kashiwa-no-ha. This year’s winner: Entomal Biotech from Malaysia, offering biotech waste management solution that converts organic waste into insect protein and fertilizer. Kisui TECH from Japan wins Kashiwa-no-ha Award and places third overall with its autonomous AI off-road platform supporting agriculture. (Photo: Business Wire)

Entrepreneurs from Asian Countries and Regions Compete at AEA2024 Innovation Award held in Kashiwa-no-ha. This year’s winner: Entomal Biotech from Malaysia, offering biotech waste management solution that converts organic waste into insect protein and fertilizer. Kisui TECH from Japan wins Kashiwa-no-ha Award and places third overall with its autonomous AI off-road platform supporting agriculture. (Photo: Business Wire)

The Asian Entrepreneurship Award aims to help create an innovation ecosystem in Asia by bringing together young entrepreneurs from fast-growing Asian countries with Japanese investors, established major companies and other startup supporters from those countries.  


2024 Awards  

First Prize: Entomal Biotech Sdn. Bhd. (Malaysia) www.entomal.com  

Entomal Biotech is a startup offering innovative and proprietary bioconversion technology that utilizes black soldier ants to convert food and other organic waste into high-quality insect protein and nutrient-rich fertilizer in just seven days. The solution can be used in small mobile systems or in large-scale processing facilities to handle diverse waste volumes. The company is a leader in sustainable waste management with a successful track record in a number of Asian countries including Malaysia and Korea.  


Second Prize: Formus (New Zealand): http://www.formus.com  

Formus provides innovative technology that combines AI automation and computational biomechanics to deliver personalized orthopedic care. The company’s 3D hip replacement planning software, the result of 20 years of research at the Auckland Biomedical Engineering Institute, is FDA-, PMDA- and TGA-certified and has been deployed in over 3,000 surgical procedures. Building on its success in Australia and New Zealand, Formus has partnered with Zimmer Biomet to roll out its solution in the Japanese market, aiming for commercial deployment in early 2025, leveraging the high penetration rate of CT imaging and surgical technology levels in the country.  


3rd Prize: Kisui TECH Co. Ltd. (Japan): https://kisui.ai/en  

Kisui has developed an autonomous AI off-road platform called “Adam” – a modular machine that can undertake a variety of tasks such as transporting goods, mowing fields and applying pesticides, collecting data while it operates. The platform is designed to reduce workload and improve efficiency, particularly in primary sectors such as agriculture and construction that are facing labor shortages in Japan. Its suitability and usefulness have been confirmed in fields and farms across Japan, and the company has also received significant interest from Spain, Indonesia and the United States. The multinational Kisui team is leveraging their expertise in space robotics and AI to deploy some of the world's most advanced technology.  


Kashiwa-no-ha Award: Kisui TECH Co. Ltd. (Japan): https://kisui.ai/en  


Fujitsu Accelerator Award  

Winner: Kisui TECH Co. Ltd. (Japan): https://kisui.ai/en  


IP Bridge Award  

Winner: TOPOLOGIC (Japan): https://www.topologic.jp/en  

Leveraging research conducted at the University of Tokyo, TOPOLOGIC has developed high-performance semiconductor technologies that take advantage of the properties of topological materials. They include TL-RAM, a high-speed energy-saving non-volatile memory that performs 10 times faster than conventional memory, and TL-SENSING, a MEMS thermal sensor that detects thermal fluctuations 100 times faster than conventional MEMS sensors. The company has filed 30+ patents since 2022 and the University of Tokyo has secured an exclusive license for the basic patent. Joint demonstrations are underway attended by specialists from the automotive, industrial equipment, and semiconductor industries.  


Life Science Award  

Winner: CancerFree Biotech (Taiwan): https://cancerfree.io/  

CancerFree Biotech provides technology that generates 3D tumor organoids from patients' blood in order to test the efficacy of cancer drugs. The company helps enable precision medicine and new drug development using organoids that reflect tumor characteristics that differ from patient to patient. To date, the company has processed more than 1,500 cases and has partnered with more than 60 medical institutions in Taiwan.  


The Academic Society for Ventures and Entrepreneurs Award  

Winner: KroniKare Pte Ltd (Singapore): www.kronikare.ai  

The company developed and launched the KroniKare Wound Scanner, an innovative AI-powered chronic wound management system as a research project in 2017. The system automates the assessment and management of chronic wounds caused by diabetes, cardiovascular disease, obesity, and aging. It is now commercialized, CE Mark-certified, and is being deployed in Europe. Japan, with its aging population and large number of diabetic patients, is seen as an important market.  


Audience Award  

Winner: CancerFree Biotech (Taiwan): https://cancerfree.io/  


List of Finalists  

Company Name

Country

Category

CancerFree Biotech

Taiwan

Healthcare / Medical

Ex Vivo Avatar (EVA) Original Platform Creates 3D Tumor Organoids from Patients' Blood to Test Personalized Cancer Drugs

Kisui TECH Co. Ltd.

Japan

Agricultural Transportation / Infrastructure

Developed an autonomous AI off-road platform using modular technology to streamline various tasks in primary sectors such as agriculture and construction

Formus

New Zealand

Healthcare / Medical

Uses AI-driven automation to optimize joint replacement surgery and patient-specific bone and soft tissue modeling

KroniKare Pte Ltd

Singapore

Healthcare / Medical

Has developed a breakthrough AI-powered solution that automates the assessment and management of chronic wounds caused by diabetes, cardiovascular disease, obesity, aging, and more.

Entomal Biotech Sdn. Bhd.

Malaysia

Food / Agriculture / Environment

Waste management solution that utilizes black soldier flies to convert organic waste into insect protein and fertilizer with bioconversion technology

Kenkone Medical Co., Ltd

Taiwan

AI / IoT / Software / Healthcare / Medical

Generative AI and voice recognition technology assists in the creation of records during surgery to maximize the quality of care for patients while reducing the burden on healthcare professionals

The companies are listed in the order in which they presented at the final session.  

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (“Kalkine Media, we or us”) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalized advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media.
The content published on Kalkine Media also includes feeds sourced from third-party providers. Kalkine does not assert any ownership rights over the content provided by these third-party sources. The inclusion of such feeds on the Website is for informational purposes only. Kalkine does not guarantee the accuracy, completeness, or reliability of the content obtained from third-party feeds. Furthermore, Kalkine Media shall not be held liable for any errors, omissions, or inaccuracies in the content obtained from third-party feeds, nor for any damages or losses arising from the use of such content. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.
This disclaimer is subject to change without notice. Users are advised to review this disclaimer periodically for any updates or modifications.


Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.